Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 117, 2011 - Issue 3
309
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues

, &
Pages 131-139 | Received 26 Dec 2010, Accepted 20 Jan 2011, Published online: 11 Mar 2011

References

  • Ando K, Fujita T. (2009). Metabolic syndrome and oxidative stress. Free Radic Biol Med 47:213–18.
  • Awasthi YC, Yang Y, Tiwari NK, Patrick B, Sharma A, Li J, Awasthi S. (2004). Regulation of 4-hydroxynonenal-mediated signaling by glutathione s-transferases. Free Radic Biol Med 37:607–19.
  • Bacot S, Bernoud-Hubac N, Baddas N, Chantegrel B, Deshayes C, Doutheau A, Lagarde M, Guichardant M. (2003). Covalent binding of hydroxy-alkenals 4-hdde, 4-hhe, and 4-hne to ethanolamine phospholipid subclasses. J Lipid Res 44:917–26.
  • Bacot S, Bernoud-Hubac N, Chantegrel B, Deshayes C, Doutheau A, Ponsin G, Lagarde M, Guichardant M. (2007). Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals. J Lipid Res 48:816–25.
  • Belkner J, Chaitidis P, Stender H, Gerth C, Kuban RJ, Yoshimoto T, Kuhn H. (2005). Expression of 12/15-lipoxygenase attenuates intracellular lipid deposition during in vitro foam cell formation. Arterioscler Thromb Vasc Biol 25:797–802.
  • Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, Leonarduzzi G, Poli G. (2006). C-jun n-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med 41:443–54.
  • Bourlier V, Bouloumie A. (2009). Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab 35:251–60.
  • Bruce KD, Byrne CD. (2009). The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 85:614–21.
  • Buczynski MW, Dumlao DS, Dennis EA. (2009). Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50:1015–38.
  • Bui PH, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O. (2011). Human cytochrome p450, cyp2s1, metabolizes cyclooxygenase− and lipoxygenase− derived eicosanoids. Drug Metab Dispos 39:180–190.
  • Burke JE, Dennis EA. (2009). Phospholipase a2 structure/function, mechanism, and signaling. J Lipid Res 50 Suppl:S237–42.
  • Canuto RA, Ferro M, Muzio G, Bassi AM, Leonarduzzi G, Maggiora M, Adamo D, Poli G, Lindahl R. (1994). Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis 15:1359–64.
  • Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL. (2009). 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes. Obesity (Silver Spring) 17:1657–63.
  • Chakrabarti SK, Wen Y, Dobrian AD, Cole BK, Ma Q, Pei H, Williams MD, Bevard MH, Vandenhoff GE, Keller SR, Gu J, Nadler JL. (2011). Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese zucker rats. Am J Physiol Endocrinol Metab 300:E175–E187.
  • Chen ZH, Niki E. (2006). 4-hydroxynonenal (4-hne) has been widely accepted as an inducer of oxidative stress. Is this the whole truth about it or can 4-hne also exert protective effects? IUBMB Life 58:372–3.
  • Coleman JD, Prabhu KS, Thompson JT, Reddy PS, Peters JM, Peterson BR, Reddy CC, Vanden Heuvel JP. (2007). The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (pparbeta/delta). Free Radic Biol Med 42:1155–64.
  • Demozay D, Mas JC, Rocchi S, Van Obberghen E. (2008). Faldh reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3t3-l1 adipocytes. Diabetes 57:1216–26.
  • Devaraj S, Wang-Polagruto J, Polagruto J, Keen CL, Jialal I. (2008). High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 57:867–70.
  • Dianzani MU. (2003). 4-hydroxynonenal from pathology to physiology. Mol Aspects Med 24:263–72.
  • Duncan RE, Sarkadi-Nagy E, Jaworski K, Ahmadian M, Sul HS. (2008). Identification and functional characterization of adipose-specific phospholipase a2 (adpla). J Biol Chem 283:25428–36.
  • Dwivedi S, Sharma A, Patrick B, Sharma R, Awasthi YC. (2007). Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep 12:4–10.
  • Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin M, Pamplona R, Vidal-Puig AJ, Wang S, Roebuck SJ et al. (2003). A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22:4103–10.
  • Eckardt K, Sell H, Eckel J. (2008). Novel aspects of adipocyte-induced skeletal muscle insulin resistance. Arch Physiol Biochem 114:287–98.
  • Engle MR, Singh SP, Czernik PJ, Gaddy D, Montague DC, Ceci JD, Yang Y, Awasthi S, Awasthi YC, Zimniak P. (2004). Physiological role of mgsta4-4, a glutathione s-transferase metabolizing 4-hydroxynonenal: Generation and analysis of mgsta4 null mouse. Toxicol Appl Pharmacol 194:296–308.
  • Esterbauer H, Schaur RJ, Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128.
  • Esteve E, Ricart W, Fernandez-Real JM. (2009). Adipocytokines and insulin resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 32 Suppl 2:S362–7.
  • Furstenberger G, Epp N, Eckl KM, Hennies HC, Jorgensen C, Hallenborg P, Kristiansen K, Krieg P. (2007). Role of epidermis-type lipoxygenases for skin barrier function and adipocyte differentiation. Prostaglandins Other Lipid Mediat 82:128–34.
  • Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. (2010). Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: Role of atgl, hsl, and ampk. Am J Physiol Cell Physiol 298:C961–71
  • Galic S, Oakhill JS, Steinberg GR. (2010). Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316:129–39.
  • Gardner HW, Hamberg M. (1993). Oxygenation of (3z)-nonenal to (2e)-4-hydroxy-2-nonenal in the broad bean (vicia faba l.). J Biol Chem 268:6971–7.
  • Grimsrud PA, Picklo MJ, Sr. Griffin, TJ, Bernlohr DA. (2007). Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 6:624–37.
  • Grune T, Davies KJ. (2003). The proteasomal system and hne-modified proteins. Mol Aspects Med 24:195–204.
  • Gueraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L, Jouanin I, Siems W, Uchida K. (2010). Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44:1098–124.
  • Guichardant M, Bacot S, Moliere P, Lagarde M. (2006). Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot Essent Fatty Acids 75:179–82.
  • Guichardant M, Chantegrel B, Deshayes C, Doutheau A, Moliere P, Lagarde M. (2004). Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochem Soc Trans 32:139–40.
  • Guilherme A, Virbasius JV, Puri V, Czech MP. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367–77.
  • Guzik TJ, Mangalat D, Korbut R. (2006). Adipocytokines− novel link between inflammation and vascular function? J Physiol Pharmacol 57:505–28.
  • Hallenborg P, Jorgensen C, Petersen RK, Feddersen S, Araujo P, Markt P, Langer T, Furstenberger G, Krieg P, Koppen A, et al (2010). Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity. Mol Cell Biol 30:4077–91.
  • Hotamisligil GS. (2006). Inflammation and metabolic disorders. Nature 444:860–7.
  • Huo Y, Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, et al. (2004). Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein e-deficient mice. Circulation 110:2024–31.
  • Ii H, Hatakeyama S, Tsutsumi K, Sato T, Akiba S. (2008). Group iva phospholipase a2 is associated with the storage of lipids in adipose tissue and liver. Prostaglandins Other Lipid Mediat 86:12–7.
  • Jaworski K, Ahmadian M, Duncan RE, Sarkadi-Nagy E, Varady KA, Hellerstein MK, Lee HY, Samuel VT, Shulman GI, Kim KH, et al. (2009). Adpla ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med 15:159–68.
  • Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. (2009). Mechanisms of obesity and related pathology: Linking immune responses to metabolic stress. FEBS J 276:5747–54.
  • Kawajiri H, Zhuang D, Qiao N, Yoshimoto T, Yamamoto M, Iseki S, Hamaguchi K. (2000). Expression of arachidonate 12-lipoxygenase in rat tissues: A possible role in glucagon secretion. J Histochem Cytochem 48:1411–9.
  • Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. (2003). Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the framingham study. Arterioscler Thromb Vasc Biol 23:434–9.
  • Lamers D, Schlich R, Greulich S, Sasson S, Sell H, Eckel J. (2011). Oleic acid and adipokines synergize in inducing proliferation and inflammatory signaling in human vascular smooth muscle cells. J Cell Mol Med, Epub ahead of print..
  • Leonarduzzi G, Arkan MC, Basaga H, Chiarpotto E, Sevanian A, Poli G. (2000). Lipid oxidation products in cell signaling. Free Radic Biol Med 28:1370–8.
  • Long SD, Pekala PH. (1996). Regulation of glut4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin e2. J Biol Chem 271:1138–44.
  • Madsen L, Petersen RK, Sorensen MB, Jorgensen C, Hallenborg P, Pridal L, Fleckner J, Amri EZ, Krieg P, Furstenberger G, et al. (2003). Adipocyte differentiation of 3t3-l1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem J 375:539–49.
  • Martinez JA. (2006). Mitochondrial oxidative stress and inflammation: A slalom to obesity and insulin resistance. J Physiol Biochem 62:303–6.
  • Mattson MP. (2009). Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 44:625–33.
  • Niki E. (2009). Lipid peroxidation: Physiological levels and dual biological effects. Free Radic Biol Med 47:469–84.
  • Nugent C, Prins JB, Whitehead JP, Wentworth JM, Chatterjee VK, O’Rahilly S. (2001). Arachidonic acid stimulates glucose uptake in 3t3-l1 adipocytes by increasing glut1 and glut4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem 276:9149–57.
  • Nunemaker CS, Chen M, Pei H, Kimble SD, Keller SR, Carter JD, Yang Z, Smith KM, Wu R, Bevard MH, et al. (2008). 12-lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by western diet. Am J Physiol Endocrinol Metab 295:E1065–75
  • Olefsky JM, Glass CK. (2010). Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219–46.
  • Orioli M, Aldini G, Benfatto MC, Facino RM, Carini M. (2007). Hne michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: Lc-ms/ms profiling in zucker obese rats. Anal Chem 79:9174–84.
  • Park Y, Pariza MW. (2001). Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3t3-l1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid. Biochim Biophys Acta 1534:27–33.
  • Petersen DR, Doorn JA. (2004). Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 37:937–45.
  • Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. (2004). Oxidative stress and cell signalling. Curr Med Chem 11:1163–82.
  • Pryor WA, Porter NA. (1990). Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic Biol Med 8:541–3.
  • Rasouli N, Kern PA. (2008). Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64–73
  • Riahi Y, Cohen G, Shamni O, Sasson S. (2010a). Signaling and cytotoxic functions of 4-hydroxyalkenals. Am J Physiol Endocrinol Metab 299:E879–86
  • Riahi Y, Sin-Malia Y, Cohen G, Alpert E, Gruzman A, Eckel J, Staels B, Guichardant M, Sasson S. (2010b). The natural protective mechanism against hyperglycemia in vascular endothelial cells: Roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta. Diabetes 59:808–18.
  • Ronti T, Lupattelli G, Mannarino E. (2006). The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64:355–65.
  • Russell AP, Gastaldi G, Bobbioni-Harsch E, Arboit P, Gobelet C, Deriaz O, Golay A, Witztum JL, Giacobino JP. (2003). Lipid peroxidation in skeletal muscle of obese as compared to endurance–trained humans: A case of good vs. Bad lipids? FEBS Lett 551:104–6.
  • Schaloske RH, Dennis EA. (2006). The phospholipase a2 superfamily and its group numbering system. Biochim Biophys Acta 1761:1246–59.
  • Schaur RJ. (2003). Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 24:149–59.
  • Schneider C. (2009). An update on products and mechanisms of lipid peroxidation. Mol Nutr Food Res 53:315–21.
  • Schneider C, Porter NA, Brash AR. (2008). Routes to 4-hydroxynonenal: Fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem 283:15539–43.
  • Sears DD, Miles PD, Chapman J, Ofrecio JM, Almazan F, Thapar D, Miller YI. (2009). 12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice. PLoS One 4:e7250.
  • Sell H, Eckel J. (2009). Chemotactic cytokines, obesity and type 2 diabetes: In vivo and in vitro evidence for a possible causal correlation? Proc Nutr Soc 68:378–84.
  • Sell H, Eckel J. (2010). Adipose tissue inflammation: Novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 13:366–70.
  • Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, Arner P, Eckel J. (2009). Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58:2731–40.
  • Shillabeer G, Kumar V, Tibbo E, Lau DC. (1998). Arachidonic acid metabolites of the lipoxygenase as well as the cyclooxygenase pathway may be involved in regulating preadipocyte differentiation. Metabolism 47:461–6.
  • Shireman LM, Kripps KA, Balogh LM, Conner KP, Whittington D, Atkins WM. (2010). Glutathione transferase a4-4 resists adduction by 4-hydroxynonenal. Arch Biochem Biophys 504:182–9.
  • Singh SP, Niemczyk M, Saini D, Awasthi YC, Zimniak L, Zimniak P. (2008). Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 47:3900–11.
  • Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaidi-Tiali N, Lagarde M, Geloen A. (2005). Effects of oxidative stress on adiponectin secretion and lactate production in 3t3-l1 adipocytes. Free Radic Biol Med 38:882–9.
  • Srivastava S, Chandra A, Wang LF, Seifert WE, Jr., DaGue BB, Ansari NH, Srivastava SK, Bhatnagar A. (1998). Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem 273:10893–900.
  • Tam CS, Clement K, Baur LA, Tordjman J. (2010). Obesity and low-grade inflammation: a paediatric perspective. Obes Rev 11:118–26.
  • Taube A, Eckardt K, Eckel J. (2009). Role of lipid-derived mediators in skeletal muscle insulin resistance. Am J Physiol Endocrinol Metab 287:E1004–E1012.
  • Tebbey PW, McGowan KM, Stephens JM, Buttke TM, Pekala PH. (1994). Arachidonic acid down–regulates the insulin-dependent glucose transporter gene (glut4) in 3t3-l1 adipocytes by inhibiting transcription and enhancing mrna turnover. J Biol Chem 269:639–44.
  • Tejero I, Gonzalez-Lafont A, Lluch JM, Eriksson LA. (2007). Theoretical modeling of hydroxyl-radical-induced lipid peroxidation reactions. J Phys Chem B 111:5684–93.
  • Toyokuni S, Yamada S, Kashima M, Ihara Y, Yamada Y, Tanaka T, Hiai H, Seino Y, Uchida K. (2000). Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid Redox Signal 2:681–5.
  • Traverso N, Menini S, Odetti P, Pronzato MA, Cottalasso D, Marinari UM. (2002). Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic Biol Med 32:350–9.
  • Uchida K. (2003). 4-hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog Lipid Res 42:318–43.
  • Uchida Y, Ohba K, Yoshioka T, Irie K, Muraki T, Maru Y. (2004). Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway. J Biol Chem 279:4075–83.
  • Vincent HK, Powers SK, Dirks AJ, Scarpace PJ. (2001). Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord 25:378–88.
  • Wen Y, Gu J, Vandenhoff GE, Liu X, Nadler JL. (2008). Role of 12/15-lipoxygenase in the expression of mcp-1 in mouse macrophages. Am J Physiol Heart Circ Physiol 294:H1933–8
  • Wolf G. (2009). Adipose-specific phospholipase as regulator of adiposity. Nutr Rev 67:551–4.
  • Xiao WJ, He JW, Zhang H, Hu WW, Gu JM, Yue H, Gao G, Yu JB, Wang C, Ke YH, et al. (2010). Alox12 polymorphisms are associated with fat mass but not peak bone mineral density in chinese nuclear families. Int J Obes (Lond), Epub ahead of print.
  • Yan J, Hales BF. (2006). Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in the organogenesis stage mouse embryo. J Pharmacol Exp Ther 319:613–21.
  • Yang Y, Xu Y, Lick SD, Awasthi YC, Boor PJ. (2008). Endothelial glutathione-s-transferase a4-4 protects against oxidative stress and modulates inos expression through nf-kappab translocation. Toxicol Appl Pharmacol 230:187–96.
  • Yoshimoto T, Takahashi Y. (2002). Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat, 68–69:245–62.
  • Zarkovic N. (2003). 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24:281–91.
  • Zarrouki B, Soares AF, Guichardant M, Lagarde M, Geloen A. (2007). The lipid peroxidation end-product 4-hne induces cox-2 expression through p38mapk activation in 3t3-l1 adipose cell. FEBS Lett 581:2394–400.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.